tiprankstipranks
bluebird bio (BLUE)
NASDAQ:BLUE
Holding BLUE?
Track your performance easily

Bluebird Bio (BLUE) Financial Statements

2,800 Followers

Bluebird Bio Financial Overview

Bluebird Bio's market cap is currently ―. The company's EPS TTM is $-35.974; its P/E ratio is -0.24; Bluebird Bio is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-5.97. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 10.61M$ 16.10M$ 18.57M$ 7.83M$ 12.39M
Gross Profit$ -1.17M$ -12.85M$ -7.29M$ -1.80M$ 1.44M
EBIT$ -58.54M$ -78.68M$ -64.94M$ -72.18M$ -84.73M
EBITDA$ -43.20M$ -62.16M$ -49.48M$ -46.78M$ -83.66M
Net Income Common Stockholders$ -60.81M$ -81.39M$ -69.80M$ -88.51M$ -71.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 70.65M$ 144.07M$ 212.05M$ 221.80M$ 174.29M
Total Assets$ 465.06M$ 545.19M$ 631.48M$ 619.16M$ 613.61M
Total Debt$ 365.02M$ 390.42M$ 414.34M$ 330.33M$ 303.71M
Net Debt$ 294.37M$ 246.35M$ 202.29M$ 108.53M$ 129.41M
Total Liabilities$ 470.84M$ 492.21M$ 500.44M$ 424.62M$ 391.07M
Stockholders Equity$ -5.79M$ 52.98M$ 131.05M$ 194.54M$ 222.54M
Cash Flow-
Free Cash Flow$ -69.21M$ -66.31M$ -76.45M$ -111.94M$ -63.88M
Operating Cash Flow$ -68.93M$ -66.25M$ -74.68M$ -13.79M$ -61.85M
Investing Cash Flow$ 466.00K$ 1.62M$ -655.00K$ 3.79M$ 62.08M
Financing Cash Flow$ -6.11M$ -6.06M$ 64.64M$ 66.28M$ -42.00K
Currency in USD

Bluebird Bio Earnings and Revenue History

Bluebird Bio Debt to Assets

Bluebird Bio Cash Flow

Bluebird Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis